Gasparri ML - Search Results

1

Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds.

Farooqi AA, Desai NN, Qureshi MZ, Librelotto DRN, Gasparri ML, Bishayee A, Nabavi SM, Curti V, Daglia M. Farooqi AA, et al. Among authors: gasparri ml. Biotechnol Adv. 2018 Jan-Feb;36(1):328-334. doi: 10.1016/j.biotechadv.2017.12.010. Epub 2017 Dec 14. Biotechnol Adv. 2018. PMID: 29248680 Review.

2

Drugs from marine sources: modulation of TRAIL induced apoptosis in cancer cells.

Farooqi AA, Attar R, Gasparri ML. Farooqi AA, et al. Among authors: gasparri ml. Asian Pac J Cancer Prev. 2014;15(20):9045-7. doi: 10.7314/apjcp.2014.15.20.9045. Asian Pac J Cancer Prev. 2014. PMID: 25374250 Free article.

3

Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overcome Metastasis and Drug Resistance.

Butt G, Shahwar D, Qureshi MZ, Attar R, Akram M, Birinci Y, Karatoprak GS, Gasparri ML, Farooqi AA. Butt G, et al. Among authors: gasparri ml. Adv Exp Med Biol. 2019;1152:283-292. doi: 10.1007/978-3-030-20301-6_15. Adv Exp Med Biol. 2019. PMID: 31456190 Review.

4

Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386).

Marchetti C, Gasparri ML, Ruscito I, Palaia I, Perniola G, Carrone A, Farooqi AA, Pecorini F, Muzii L, Panici PB. Marchetti C, et al. Among authors: gasparri ml. Crit Rev Oncol Hematol. 2015 Jun;94(3):302-10. doi: 10.1016/j.critrevonc.2015.02.001. Epub 2015 Mar 4. Crit Rev Oncol Hematol. 2015. PMID: 25783620 Review.

5

Oleuropein Mediated Targeting of Signaling Network in Cancer.

Fayyaz S, Aydin T, Cakir A, Gasparri ML, Panici PB, Farooqi AA. Fayyaz S, et al. Among authors: gasparri ml. Curr Top Med Chem. 2016;16(22):2477-83. doi: 10.2174/1568026616666160212123706. Curr Top Med Chem. 2016. PMID: 26873189 Review.

6

Dealing naturally with stumbling blocks on highways and byways of TRAIL induced signaling.

Rana A, Attar R, Qureshi MZ, Gasparri ML, Donato VD, Ali GM, Farooqi AA. Rana A, et al. Among authors: gasparri ml. Asian Pac J Cancer Prev. 2014;15(19):8041-6. doi: 10.7314/apjcp.2014.15.19.8041. Asian Pac J Cancer Prev. 2014. PMID: 25338981 Free article. Review.

7

PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?

Gasparri ML, Bardhi E, Ruscito I, Papadia A, Farooqi AA, Marchetti C, Bogani G, Ceccacci I, Mueller MD, Benedetti Panici P. Gasparri ML, et al. Geburtshilfe Frauenheilkd. 2017 Oct;77(10):1095-1103. doi: 10.1055/s-0043-118907. Epub 2017 Oct 26. Geburtshilfe Frauenheilkd. 2017. PMID: 29093603 Free PMC article.

8

Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?

Farooqi AA, Fayyaz S, Shatynska-Mytsyk I, Javed Z, Jabeen S, Yaylim I, Gasparri ML, Panici PB. Farooqi AA, et al. Among authors: gasparri ml. Chem Biol Drug Des. 2016 Mar;87(3):321-34. doi: 10.1111/cbdd.12634. Epub 2016 Jan 13. Chem Biol Drug Des. 2016. PMID: 26259537 Review.

9

Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.

Gasparri ML, Savone D, Besharat RA, Farooqi AA, Bellati F, Ruscito I, Panici PB, Papadia A. Gasparri ML, et al. Tumour Biol. 2016 Jan;37(1):71-5. doi: 10.1007/s13277-015-4299-9. Epub 2015 Oct 26. Tumour Biol. 2016. PMID: 26500096 Review.

10

Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer.

Gasparri ML, Casorelli A, Bardhi E, Besharat AR, Savone D, Ruscito I, Farooqi AA, Papadia A, Mueller MD, Ferretti E, Benedetti Panici P. Gasparri ML, et al. Tumour Biol. 2017 May;39(5):1010428317695525. doi: 10.1177/1010428317695525. Tumour Biol. 2017. PMID: 28459207 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page